Literature DB >> 17916432

mGlu4 potentiation of K(2P)2.1 is dependant on C-terminal dephosphorylation.

Stuart M Cain1, Helen J Meadows, John Dunlop, Trevor J Bushell.   

Abstract

Two-pore domain potassium (K(2P)) channels are proposed to underlie the background or leak current found in many excitable cells. Extensive studies have been performed investigating the inhibition of K(2P)2.1 by Galpha(q)- and Galpha(s)-coupled G-protein-coupled receptors (GPCRs), whereas in the present study we investigate the mechanisms underlying Galpha(i)/Galpha(o)-coupled GPCR increases in K(2P)2.1 activity. Activation of mGlu4 increases K(2P)2.1 activity, with pharmacological inhibition of protein kinases and phosphatases revealing the involvement of PKA whereas PKC, PKG or protein phosphatases play no role. Mutational analysis of potential C-terminal phosphorylation sites indicates S333 to control approximately 70%, with S300 controlling approximately 30% of the increase in K(2P)2.1 activity following mGlu4 activation. These data reveal that activation of mGlu4 leads to an increase in K(2P)2.1 activity through a reduction in C-terminal phosphorylation, which represents a novel mechanism by which group III mGlu receptors may regulate cell excitability and synaptic activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916432     DOI: 10.1016/j.mcn.2007.08.009

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  12 in total

1.  PKC-dependent activation of human K(2P) 18.1 K(+) channels.

Authors:  Ann-Kathrin Rahm; Jakob Gierten; Jana Kisselbach; Ingo Staudacher; Kathrin Staudacher; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Optical control of endogenous proteins with a photoswitchable conditional subunit reveals a role for TREK1 in GABA(B) signaling.

Authors:  Guillaume Sandoz; Joshua Levitz; Richard H Kramer; Ehud Y Isacoff
Journal:  Neuron       Date:  2012-06-21       Impact factor: 17.173

3.  A new signalling pathway for parallel fibre presynaptic type 4 metabotropic glutamate receptors (mGluR4) in the rat cerebellar cortex.

Authors:  Karine Abitbol; Heather McLean; Thomas Bessiron; Hervé Daniel
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

4.  Potassium channel silencing by constitutive endocytosis and intracellular sequestration.

Authors:  Sylvain Feliciangeli; Magalie P Tardy; Guillaume Sandoz; Franck C Chatelain; Richard Warth; Jacques Barhanin; Saïd Bendahhou; Florian Lesage
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

Review 5.  Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain.

Authors:  Alistair Mathie; Emma L Veale
Journal:  Pflugers Arch       Date:  2014-11-26       Impact factor: 3.657

6.  GABAB receptors suppress burst-firing in reticular thalamic neurons.

Authors:  Stuart M Cain; Esperanza Garcia; Zeina Waheed; Karen L Jones; Trevor J Bushell; Terrance P Snutch
Journal:  Channels (Austin)       Date:  2017-08-22       Impact factor: 2.581

Review 7.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

8.  Group III metabotropic glutamate receptors and transient receptor potential vanilloid 1 co-localize and interact on nociceptors.

Authors:  R M Govea; S Zhou; S M Carlton
Journal:  Neuroscience       Date:  2012-05-17       Impact factor: 3.590

Review 9.  Molecular regulations governing TREK and TRAAK channel functions.

Authors:  Jacques Noël; Guillaume Sandoz; Florian Lesage
Journal:  Channels (Austin)       Date:  2011-09-01       Impact factor: 2.581

10.  Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage.

Authors:  Slavianka G Moyanova; Federica Mastroiacovo; Lidia V Kortenska; Rumiana G Mitreva; Erminia Fardone; Ines Santolini; Mónica Sobrado; Giuseppe Battaglia; Valeria Bruno; Ferdinando Nicoletti; Richard T Ngomba
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-15       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.